BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 4
• 5
• 6
• 7
• 10
• 11
• 12
• 13
• 14
• 17
• 18
• 19
• 20
• 21
• 24
• 25
• 26
• 27
• 28

• Drug Development

  Zealand Pharma Advances ZP2929 Into Phase I Development for the Treatment of Type 2 Diabetes and/or Obesity

  September 13, 2012

   · 

  1 min read
• Business

  REVA Medical Inc. Announces Dr. David Muller as Co-Principal Investigator for RESTORE II Clinical Trial

  September 13, 2012

   · 

  1 min read
• Business

  Pacific Biosciences Appoints Lucy Shapiro, Ph.D. to Board of Directors

  September 13, 2012

   · 

  1 min read
• Pluristem Therapeutics Announces Proposed Public Offering of Common Stock and Warrants to Purchase Common Stock

  September 13, 2012

   · 

  1 min read
• Drug Development

  Repros Therapeutics Inc. Provides Clinical Update for Androxal® Phase 3 Program

  September 13, 2012

   · 

  1 min read
• Drug Development

  NovaBay Pharmaceuticals, Inc. Co-Authors Novel Study Demonstrating Chemical Impact of N-Chlorotaurine and NVC-422 on Bacterial Toxins

  September 13, 2012

   · 

  1 min read
• Drug Development

  Nymox Pharmaceutical Reports Positive Safety Monitoring Committee Results for Pivotal Phase 3 Trials

  September 13, 2012

   · 

  1 min read
• Business

  Omnicare, Inc. Names Workman CEO

  September 13, 2012

   · 

  1 min read
• Biotech Bay

  Trius Therapeutics Reports Data on Broad-Spectrum Antibiotics at 52nd Annual ICAAC Meeting

  September 13, 2012

   · 

  1 min read
• Genetown

  Sarepta Therapeutics (Formerly known as AVI BioPharma, Inc.) to Present Company Overview at the 2012 UBS Global Life Sciences Conference

  September 13, 2012

   · 

  1 min read